Genetic aspects of Alzheimer disease

被引:187
作者
Bird, Thomas D. [1 ]
机构
[1] Univ Washington, Ctr Geriatr Res Educ & Clin, VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA
关键词
Alzheimer; dementia; amyloid; neurogenetics;
D O I
10.1097/GIM.0b013e31816b64dc
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Alzheimer disease is the most common cause of dementia and represents a major public health problem. The neuropathologic findings of amyloid-beta plaques and tau containing neurofibrillary tangles represent important molecular clues to the underlying pathogenesis. Genetic factors are well recognized, but complicated. Three rare forms of autosomal-dominant early-onset familial Alzheimer disease have been identified and are associated with mutations in amyloid precursor protein, presenilin 1, and presenilin 2 genes. The more common late-onset form of Alzheimer disease is assumed to be polygenic/multifactorial. However, thus far the only clearly identified genetic risk factor for Alzheimer disease is Apo lipoprotein E. The epsilon 4 allele of Apo lipoprotein E influences age at onset of Alzheimer disease, but is neither necessary nor Sufficient for the disease. The search continues for the discovery of additional genetic influences.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 113 条
  • [21] α2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease
    Depboylu, Candan
    Lohmueller, Frank
    Du, Yansheng
    Riemenschneider, Matthias
    Kurz, Alexander
    Gasser, Thomas
    Mueller, Ulrich
    Dodel, Richard C.
    [J]. NEUROSCIENCE LETTERS, 2006, 400 (03) : 187 - 190
  • [22] α2 macroglobulin and the risk of Alzheimer's disease
    Dodel, RC
    Du, Y
    Bales, KR
    Gao, F
    Eastwood, B
    Glazier, B
    Zimmer, R
    Cordell, B
    Hake, A
    Evans, R
    Gallagher-Thompson, D
    Thompson, LW
    Tinklenberg, JR
    Pfefferbaum, A
    Sullivan, EV
    Yesavage, J
    Altstiel, L
    Gasser, T
    Farlow, MR
    Murphy, GM
    Paul, SM
    [J]. NEUROLOGY, 2000, 54 (02) : 438 - 442
  • [23] Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
    Ertekin-Taner, N
    Graff-Radford, N
    Younkin, LH
    Eckman, C
    Baker, M
    Adamson, J
    Ronald, J
    Blangero, J
    Hutton, M
    Younkin, SG
    [J]. SCIENCE, 2000, 290 (5500) : 2303 - +
  • [24] FATTER LA, 1989, ANN NEUROL, V25, P485
  • [25] Economic evaluation of donepezil in moderate to severe Alzheimer disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Hux, M
    Xu, Y
    Schwam, EM
    Shah, S
    Mastey, V
    [J]. NEUROLOGY, 2004, 63 (04) : 644 - 650
  • [26] Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease
    Ferrer, I
    Rovira, MB
    Guerra, MLS
    Rey, MJ
    Costa-Jussá, F
    [J]. BRAIN PATHOLOGY, 2004, 14 (01) : 11 - 20
  • [27] Role of genes and environments for explaining Alzheimer disease
    Gatz, M
    Reynolds, CA
    Fratiglioni, L
    Johansson, B
    Mortimer, JA
    Berg, S
    Fiske, A
    Pedersen, NL
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (02) : 168 - 174
  • [28] Lack of association of the α2-macroglobulin locus on chromosome 12 in AD
    Gibson, AM
    Singleton, AB
    Smith, G
    Woodward, R
    McKeith, IG
    Perry, RH
    Ince, PG
    Ballard, CG
    Edwardson, JA
    Morris, CM
    [J]. NEUROLOGY, 2000, 54 (02) : 433 - 438
  • [29] Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
    Gilman, S
    Koller, M
    Black, RS
    Jenkins, L
    Griffith, SG
    Fox, NC
    Eisner, L
    Kirby, L
    Rovira, MB
    Forette, F
    Orgogozo, JM
    [J]. NEUROLOGY, 2005, 64 (09) : 1553 - 1562
  • [30] The natural history of Alzheimer disease - A longitudinal presymptomatic and symptomatic study of a familial cohort
    Godbolt, AK
    Cipolotti, L
    Watt, H
    Fox, NC
    Janssen, JC
    Rossor, MN
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (11) : 1743 - 1748